Completeomics
Founded 2019 · 14 employees on LinkedIn · 1 known investors
Complete Omics builds clinically reproducible proteomics and multi-omics platforms combined with AI-driven analytics for molecular diagnostics and precision medicine. Its two patented platforms, Complete360 and Valid-NEO, support liquid and tissue biopsy, disease screening, and companion diagnostics across disease categories including cardiovascular and immunology.
Investors · 1
Frequently asked questions
- What does Completeomics do?
- Complete Omics builds clinically reproducible proteomics and multi-omics platforms combined with AI-driven analytics for molecular diagnostics and precision medicine. Its two patented platforms, Complete360 and Valid-NEO, support liquid and tissue biopsy, disease screening, and companion diagnostics across disease categories including cardiovascular and immunology.
- Who are Completeomics's investors?
- Completeomics's investors include Qiming Venture Partners.